NPS PHARMACEUTICALS, INC.

Treatment of short bowel syndrome patients with colon-in-continuity

#2 | 2017-02-02 ✅ Patent 9,974,838 granted on 2018-05-22

US20170028029A1

Treatment of short bowel syndrome patients with colon-in-continuity

#3 | 2017-02-02 ✅ Patent 9,987,335 granted on 2018-06-05

US20170028028A1

Treatment of short bowel syndrome patients with colon-in-continuity

#4 | 2017-02-02 ✅ Patent 9,974,837 granted on 2018-05-22

US20170028027A1

Treatment of short bowel syndrome patients with colon-in-continuity

#5 | 2017-02-02

US20170028026A1

TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY

#6 | 2017-02-02

US20170028025A1

TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY

#7 | 2017-02-02

US20170028024A1

TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY

#8 | 2017-01-26

US20170020989A1

TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY

#9 | 2017-01-26 ✅ Patent 9,603,903 granted on 2017-03-28

US20170020988A1

Treatment of short bowel syndrome patients with colon-in-continuity

#10 | 2017-01-26

US20170020987A1

TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY

#11 | 2017-01-26 ✅ Patent 9,649,365 granted on 2017-05-16

US20170020986A1

Treatment of short bowel syndrome patients with colon-in-continuity

#12 | 2017-01-26 ✅ Patent 9,968,657 granted on 2018-05-15

US20170020985A1

Treatment of short bowel syndrome patients with colon-in-continuity

#13 | 2017-01-26

US20170020984A1

TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY

#14 | 2017-01-26 ✅ Patent 9,981,016 granted on 2018-05-29

US20170020983A1

Treatment of short bowel syndrome patients with colon-in-continuity

#15 | 2017-01-26 ✅ Patent 9,999,656 granted on 2018-06-19

US20170020982A1

Treatment of short bowel syndrome patients with colon-in-continuity

#16 | 2017-01-26 ✅ Patent 9,968,656 granted on 2018-05-15

US20170020981A1

Treatment of short bowel syndrome patients with colon-in-continuity

#17 | 2017-01-26 ✅ Patent 9,603,902 granted on 2017-03-28

US20170020980A1

Treatment of short bowel syndrome patients with colon-in-continuity

#18 | 2017-01-26 ✅ Patent 9,555,079 granted on 2017-01-31

US20170020979A1

Treatment of short bowel syndrome patients with colon-in-continuity

#19 | 2017-01-26 ✅ Patent 9,592,274 granted on 2017-03-14

US20170020978A1

Treatment of short bowel syndrome patients with colon-in-continuity

#20 | 2017-01-26 ✅ Patent 9,592,273 granted on 2017-03-14

US20170020977A1

Treatment of short bowel syndrome patients with colon-in-continuity

#21 | 2017-01-26 ✅ Patent 9,572,867 granted on 2017-02-21

US20170020976A1

Treatment of short bowel syndrome patients with colon-in-continuity

#22 | 2017-01-26 ✅ Patent 9,539,310 granted on 2017-01-10

US20170020975A1

Treatment of short bowel syndrome patients with colon-in-continuity

#23 | 2017-01-26 ✅ Patent 9,597,373 granted on 2017-03-21

US20170020974A1

Treatment of short bowel syndrome patients with colon-in-continuity

#24 | 2017-01-26 ✅ Patent 9,545,435 granted on 2017-01-17

US20170020973A1

Treatment of short bowel syndrome patients with colon-in-continuity

#25 | 2017-01-26

US20170020972A1

TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY

#26 | 2017-01-26 ✅ Patent 10,080,780 granted on 2018-09-25

US20170020971A1

Treatment of short bowel syndrome patients with colon-in-continuity

#27 | 2017-01-26 ✅ Patent 9,974,836 granted on 2018-05-22

US20170020970A1

Treatment of short bowel syndrome patients with colon-in-continuity

#28 | 2017-01-26 ✅ Patent 9,603,901 granted on 2017-03-28

US20170020969A1

Treatment of short bowel syndrome patients with colon-in-continuity

#29 | 2017-01-26

US20170020968A1

TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY

#30 | 2017-01-26 ✅ Patent 9,993,528 granted on 2018-06-12

US20170020967A1

Treatment of short bowel syndrome patients with colon-in-continuity

#31 | 2017-01-26 ✅ Patent 9,987,334 granted on 2018-06-05

US20170020966A1

Treatment of short bowel syndrome patients with colon-in-continuity

#32 | 2017-01-26 ✅ Patent 9,981,014 granted on 2018-05-29

US20170020965A1

Treatment of short bowel syndrome patients with colon-in-continuity

#33 | 2015-10-15 ✅ Patent 9,545,434 granted on 2017-01-17

US20150290296A1

Treatment of short bowel syndrome patients with colon-in-continuity

#34 | 2015-06-04

US20150153329A1

ASSAY SYSTEM FOR GLP-2 RECEPTOR LIGANDS

#35 | 2014-09-11

US20140256632A1

METHODS USEFUL IN THE TREATMENT OF BONE RESORPTION DISEASES

#36 | 2014-09-04

US20140248641A1

CLONED GLUCAGON-LIKE PEPTIDE-2 RECEPTORS

#37 | 2014-01-23 ✅ Patent 8,980,567 granted on 2015-03-17

US20140024065A1

Ex vivo method for determining potential GLP-2 receptor modulators

#38 | 2014-01-16

US20140018549A1

USE OF D-SERINE DERIVATIVES FOR THE TREATMENT OF ANXIETY DISORDERS

#39 | 2013-11-21 ✅ Patent 9,782,455 granted on 2017-10-10

US20130310314A1

Solid phase synthesis of h(Gly2)GLP-2

#40 | 2013-08-08 ✅ Patent 8,846,625 granted on 2014-09-30

US20130203673A1

Glucagon-like peptide-2 analogs

#41 | 2013-07-25

US20130190407A1

CALCIUM RECEPTOR-ACTIVE MOLECULES

#42 | 2013-06-20

US20130157954A1

METHODS FOR TREATMENT OR PROPHYLAXIS OF KIDNEY OR LIVER DYSFUNCTION

#43 | 2013-03-21

US20130072430A1

METHODS FOR TREATMENT OR PROPHYLAXIS OF KIDNEY OR LIVER DYSFUNCTION

#44 | 2012-11-29

US20120302596A1

AZAINDOLES HAVING SEROTONIN RECEPTOR AFFINITY

#45 | 2012-11-22 ✅ Patent 8,481,276 granted on 2013-07-09

US20120295298A1

Ex vivo method for determining potential GLP-2 receptor modulators

#46 | 2012-06-14 ✅ Patent 8,765,674 granted on 2014-07-01

US20120148684A1

Methods useful in the treatment of bone resorption diseases

#47 | 2012-01-05 ✅ Patent 8,257,983 granted on 2012-09-04

US20120003681A1

Ex vivo method for determining potential GLP-2 receptor modulators

#48 | 2011-07-14 ✅ Patent 9,060,992 granted on 2015-06-23

US20110172152A1

Treatment of short bowel syndrome patients with colon-in-continuity

#49 | 2011-06-02 ✅ Patent 8,148,508 granted on 2012-04-03

US20110130556A1

Method for enzymatic production of GLP-2(1-33) and GLP-2(1-34) peptides

#50 | 2011-04-21

US20110092424A1

PRODUCTION OF GLUCAGON LIKE PEPTIDE 2 AND ANALOGS

#51 | 2011-03-24 ✅ Patent 8,153,588 granted on 2012-04-10

US20110071081A1

Methods useful in the treatment of bone resorption diseases

#52 | 2011-01-13 ✅ Patent 8,933,039 granted on 2015-01-13

US20110009320A1

Glucagon-like peptide-2 analogs

#53 | 2010-08-24 ✅ Patent 7,781,401 granted on 2010-08-24

US10293941

Glucagon-like peptide-2 analogs

#54 | 2010-03-18 ✅ Patent 8,592,553 granted on 2013-11-26

US20100068732A1

Cloned glucagon-like peptide-2 receptors

#55 | 2010-01-21 ✅ Patent 8,450,336 granted on 2013-05-28

US20100016403A1

Use of D-serine derivatives for the treatment of anxiety disorders

#56 | 2010-01-07 ✅ Patent 7,977,061 granted on 2011-07-12

US20100003703A1

Ex vivo method for determining potential GLP-2 receptor modulators

#57 | 2009-07-09 ✅ Patent 7,816,408 granted on 2010-10-19

US20090176993A1

Calcium receptor active compounds

#58 | 2009-05-07 ✅ Patent 7,749,543 granted on 2010-07-06

US20090118192A1

Methods useful in the treatment of bone resorption diseases

#59 | 2009-01-06 ✅ Patent 7,473,537 granted on 2009-01-06

US9331127

Cloned glucagon-like peptide-2 receptors

#60 | 2009-01-01 ✅ Patent 7,902,401 granted on 2011-03-08

US20090005433A1

Fluorinated compounds

#61 | 2008-01-03 ✅ Patent 8,148,394 granted on 2012-04-03

US20080004307A1

Azaindoles having serotonin receptor affinity

#62 | 2007-07-05 ✅ Patent 7,498,141 granted on 2009-03-03

US20070154959A1

Assay system for GLP-2 receptor ligands

#63 | 2007-06-07 ✅ Patent 7,642,241 granted on 2010-01-05

US20070129304A1

Methods of enhancing functioning of the large intestine

#64 | 2006-06-22 ✅ Patent 7,847,061 granted on 2010-12-07

US20060135424A1

Treatment of short bowel syndrome patients with colon-in-continuity

#65 | 2006-05-18 ✅ Patent 7,888,317 granted on 2011-02-15

US20060105954A1

Glucagon-like peptide-2 and its therapeutic use

#66 | 2006-02-02 ✅ Patent 7,781,567 granted on 2010-08-24

US20060024778A1

Method for enzymatic production of GLP-2(1-33) and GLP-2(1-34) peptides

#67 | 2005-07-28 ✅ Patent 7,708,732 granted on 2010-05-04

US20050165381A1

Methods of administering therapeutic injections

#68 | 2005-07-28 ✅ Patent 7,829,307 granted on 2010-11-09

US20050164930A1